07 Jan 2001

Vigantoletten® 500 (Vigantoletten® 500/-1000 Tabletten) - Deutschland

Updated: 07 Jan 2001

Vigantoletten® 500 | -1000

Vorbeugung gegen Rachitis beim Sgl. Vorbeugung bei erkennbarem Risiko einer Vit.-D-Mangelerkrankung, Vorbeugung von Vit.-D-Mangelerscheinungen bei Verdauungsschwäche, z. B. durch chronische Darmerkrankungen, narbigen Umbau des Lebergewebes, Entfernung großer Teile des Magens oder Darms, Behandl. von Rachitis und Knochenerweichung durch Vit.-D-Mangel, unterstützende Behandl. bei Osteoporose.

Vigantoletten® 500 Description, Presentation and Dosage

Vigantoletten® 500 Description

Vigantoletten® 500 Drug Class Description

Andere Einzelstoffe

Vigantoletten® 500 Drug Description

1 Tbl. enth.: Colecalciferol 0,0125 mg/0,025 mg (entspr. 500 I.E./1000 I.E. Vit. D3).

Vigantoletten® 500 Generic Name

Vigantoletten® 500/-1000 Tabletten

Vigantoletten® 500 Presentation

Vigantoletten® 500 Presentation

Vigantoletten® 500/-1000

Vigantoletten® 500 Manufacturer

Merck

Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anticoagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Vigantoletten® 500 Dosage

Vigantoletten® 500 Adult Dosage

Siliciumdioxid, Maisstärke, Carboxymethylstärke-Natrium, Talkum, Glyceroltristearat, Cellulose, D-Mannitol, Gelatine, Saccharose, teilhydrierte Pflanzenöle (Sojaöl), 'alpha'-Tocopherol.

Vigantoletten® 500 Precautions, Reactions and Contraindications

Vigantoletten® 500 Special Precautions

Vigantoletten® 500 Special Precautions

V 15

Vigantoletten® 500 Adverse Reactions

Vigantoletten® 500 Adverse Reactions

V 15

Related Drugs - Rheumatology

Back to top